# The Food Effect on Pharmacokinetics of Fixed Dose Combination of Gemigliptin/Dapagliflozin/Metformin in Healthy Volunteers

> **NCT07396844** · PHASE1 · NOT_YET_RECRUITING · sponsor: **LG Chem** · enrollment: 28 (estimated)

## Conditions studied

- Healthy
- Fasting
- Fed

## Interventions

- **DRUG:** Fixed-dose combination of gemigliptin/dapagliflozin/metformin 50/10/1000 mg

## Key facts

- **NCT ID:** NCT07396844
- **Lead sponsor:** LG Chem
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-07-31
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07396844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07396844, "The Food Effect on Pharmacokinetics of Fixed Dose Combination of Gemigliptin/Dapagliflozin/Metformin in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07396844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*